← Back to Clinical Trials
Recruiting NCT07402655

NCT07402655 "Evaluation of the Epidemiology of Surgically Treated Acute Traumatic Peripheral Nerve Injuries of the Upper Extremity and Their Long-Term Effects on Sensory and Motor, Functional Status, and Quality of Life"

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07402655
Status Recruiting
Phase
Sponsor Suleyman Demirel University
Condition Nerve Damage
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-07-15
Primary Completion 2026-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
Peripheral Nerve Injury Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-07-15 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Assessment of the Outcomes of Hand Nerve Injuries

Eligibility Criteria

Inclusion Criteria: * Age 18 years and older * Diagnosis of acute traumatic peripheral nerve injury of the upper extremity (median, ulnar, radial, or combined injuries) * Injury requiring surgical or conservative management * Ability to provide informed consent Exclusion Criteria: * History of previous peripheral nerve injury or surgery in the affected upper extremity * Presence of central nervous system disorders affecting upper extremity function * Severe concomitant musculoskeletal injuries preventing functional assessment * Inability to complete clinical and functional evaluations

Contact & Investigator

Central Contact

halenur yaman

✉ halenurayvaci@sdu.edu.tr

📞 +905418758844

Frequently Asked Questions

Who can join the NCT07402655 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Nerve Damage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07402655 currently recruiting?

Yes, NCT07402655 is actively recruiting participants. Contact the research team at halenurayvaci@sdu.edu.tr for enrollment information.

Where is the NCT07402655 trial being conducted?

This trial is being conducted at Isparta, Turkey (Türkiye).

Who is sponsoring the NCT07402655 clinical trial?

NCT07402655 is sponsored by Suleyman Demirel University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology